Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheep model of Cln1 disease

Project Details

StatusFinished
Effective start/end date1/07/21 → 30/06/24

Funding

  • National Institutes of Health: £379,341.38